To minimize a patient's infection risk between drug treatments with a small-volume jet nebulizer (SVN), what would you do?
a. Rinse the SVN with sterile water; air dry.
b. Carefully repackage the SVN in its wet state.
c. Rinse the SVN with tap water; run until dry.
d. Throw out the SVN after every treatment.
Q. 2 A patient with an acute exacerbation of asthma is not responding to the standard dose and fre-quency of an aerosolized bronchodilator and is now receiving small-volume jet nebulizer (SVN) therapy every 30 min.
Which of the following would you recommend to the patient's physician at this time?
a. Discontinue the aerosolized bronchodila-tor.
b. Increase the frequency of SVN therapy to every 10 min.
c. Consider continuous nebulization of the drug.
d. Add more diluent to the SVN to extend treatment time.
Q. 3 What is the major problem with using large volume nebulizers for continuous aerosol drug thera-py?
a. Decreased pulmonary deposition
b. Drug reconcentration and toxicity
c. Frequent interruption of therapy
d. Greater waste of drug
Q. 4 To decrease the dead space volume of a small-volume jet nebulizer during drug administration, what should you do?
a. Decrease the nebulizer flow.
b. Turn the nebulizer upside-down.
c. Continue treatment until nebulizer begins to sputter.
d. Increase the nebulizer flow.
Q. 5 In mouth-breathing adult patients, which of the following factors is crucial in determining whether to use a mask or mouthpiece for aerosol drug delivery with a small-volume jet nebulizer?
a. Clinician experience
b. Drug concentration
c. Patient preference and comfort
d. Brand of small-volume jet nebulizer
Quick Reply
